发明名称 Pyrimidinylpiperidinyloxypyridone analogues as GPR119 modulators
摘要 Novel compounds of structure Formula I: (I) or an enantiomer, a diastereomer, or a pharmaceutically acceptable salt thereof, wherein R1, R2 and R3 are defined herein, are provided which are GPR119 G protein-coupled receptor modulators. GPR119 G protein-coupled receptor modulators are useful in treating, preventing, or slowing the progression of diseases requiring GPR119 G protein-coupled receptor modulator therapy. Thus, the disclosure also concerns compositions comprising these novel compounds and methods of treating diseases or conditions related to the activity of the GPR119 G protein-coupled receptor by using any of these novel compounds or a composition comprising any of such novel compounds.;
申请公布号 US9174965(B2) 申请公布日期 2015.11.03
申请号 US201314400758 申请日期 2013.05.13
申请人 Bristol-Myers Squibb Company 发明人 Broekema Matthias;Wu Gang;Wacker Dean A.
分类号 C07D401/14;A61K31/506;A61K31/403 主分类号 C07D401/14
代理机构 代理人 Jacobsen Barry H.
主权项 1. A compound of formula I enantiomer, diastereomer, tautomer, or salt thereof wherein: R1 is hydrogen or halo; R2 is (C1-C10)alkyl; and R3 is halo or (C1-C10)alkyl.
地址 Princeton NJ US